Archive for the 'Overall Survival' Category

Overall Survival news feed.

Quality of Life After Pleurectomy/Decortication vs. Extra Pleural Pneumonectomy

On the rare instance that mesothelioma is diagnosed in the early stages of the disease, patients have the option for surgery.  There are several surgical procedures used to treat mesothelioma. Some mesothelioma surgeries aim to provide a curative effect, while others are performed for palliative purposes. Pleurectomy/decortication (P/D) and extra pleural pneumonectomy (EPP) are two

more

Phase 1 Clinical Trial For Those With Peritoneal Mesothelioma Underway

Mesothelioma is a rare cancer affecting only about 3,000 Americans each year. Most of those diagnosed are diagnosed with pleural mesothelioma, but a small number (approx. 500 per year) are diagnosed with peritoneal mesothelioma, which is mesothelioma in the abdominal lining. With so few diagnosed with peritoneal mesothelioma, studying and evaluating the illness has been

more

Phase III Clinical Trial for Nintedanib Discontinued After Yielding Negative Results

Disappointing results from the LUME-Phase III clinical trial regarding nintedanib is a setback for scientists and researchers who were hopeful they were on the brink of finding a new, first line treatment for those suffering from mesothelioma. Results from the Phase II clinical trial – published earlier this year – showed promise for the triple

more

Survival Improves in Mesothelioma Patients who Received an Electricity-Based Treatment

The success of a recent Phase II clinical trial in malignant pleural mesothelioma has scientists and researchers excited about the possibility of adding a new treatment that will not only improve survival, but also improve quality of life of the cancer patient. Tumor Treating Fields, which is a therapy that uses alternating electric fields to

more

Decrease in Survival Rate Among Those Who Receive Non-traditional Cancer Treatment

Complementary medicine and alternative medicine may sound one in the same, but are vastly different in how each is used, and varying results often make people wary of its true effectiveness. Alternative medicine is atypical, and not used with any sort of mainstream treatment. Complementary medicine, sometimes referred to as integrative medicine, is unconventional medicine

more

Potential Breakthrough in Immunotherapy after Nivolumab Study Results

Immunotherapy treatments have once again made headlines, revolutionizing modern medicine and the way we have come to understand cancer treatment. The latest study results published in the American Journal of Case Reports, focuses on Opdivo (nivolumab), a type of check point inhibitor designed to stop immune cells from attacking the healthy cells that are needed

more

Why is Chemotherapy Often Ineffective in Those Suffering from Mesothelioma?

Mesothelioma is a difficult cancer to treat for a multitude of reasons. A mesothelioma diagnosis is rare – only about 3,000 people per year in the United States are diagnosed – and this can make it difficult to study, given that there is generally a very small sample of patients that are able to be

more

Updated Modified RECIST to Better Evaluate Treatment Response in Mesothelioma

The Response Evaluation Criteria in Solid Tumors (RECIST) was established nearly two decades ago by the European Organization for Research and Treatment of Cancer and the National Cancer Institute of the United States. The purpose of these published rules was to universally define when cancerous tumors stabilize, progress, or just respond to any given treatment.

more

Immunotherapy – What Side Effects Can You Expect?

As the success of immunotherapy treatments in improving survival and symptom management for cancer patients have started to become known, those suffering from cancer such as mesothelioma and lung cancer may now be given options in terms of the best course of treatment. Immunotherapy works with the body’s own natural defense system by strengthening and

more

Aerosol Chemotherapy – Targeting Peritoneal Mesothelioma Through Pressurized Medicine

Peritoneal mesothelioma is an incredibly rare form of cancer that affects the peritoneum, or abdominal lining. It is not entirely understood how exposure to asbestos causes this type of cancer, but scientists and researchers theorize that ingested asbestos fibers work themselves into the peritoneal cavity, or if inhaled, are transported through the lymph node system.

more

New Surgical Technique Could Be Ideal for Patients with Advanced Pleural Mesothelioma

Pleural mesothelioma is a rare and aggressive cancer that has been notoriously difficult to treat. Caused by asbestos exposure, the latency period between the time of initial exposure and disease spans decades and generally by the time the cancer is detected, it is highly advanced. Surgical treatments for those with pleural mesothelioma are generally more

more

Immunotherapy May Help Extend the Lives of Lung Cancer and Mesothelioma Patients

Immunotherapy is revolutionizing the health care industry by adding extra years of life to people with lung cancer. A few years ago it was rare for patients with an advanced stage of this disease to live past two years but today it has become more common to do so. Immunotherapy treatment works by boosting immune

more

Immunotherapy Treatment Durvalumab Enters Phase II Clinical Trial

While there is no cure for mesothelioma, those who are able to withstand surgery in general may have a better chance of survival, as the cancer is being physically removed. However, mesothelioma is a difficult cancer and often surgery is not an option, and the cancer is unresectable. The success of immunotherapy treatments for cancer

more

Biomarker CD47 as a Successful Diagnostic and Treatment Tool

Survival rates for diffuse mesothelioma are notoriously low with the median survival ranging between 12 to 22 months.  A contributing factor to treatment being ineffective is that the disease if often in the advanced stages by the time it is noticed and diagnosed. Early detection may be a key factor in fighting this illness effectively,

more

Clinical Trial Investigates Multimodality Treatment for Pleural and Peritoneal Mesothelioma

Researchers at the Memorial Sloan Kettering Cancer Center are collaborating with Pfizer to study the effects of immunotherapy treatment Avelumab when combined with stereotactic body radiation therapy, or SBRT, for those suffering from mesothelioma. SBRT treatments use a device called a linear accelerator that delivers precise and intense doses of radiation to target cancer cells

more

Last update: March 06, 2014. 08:41:31 pm.